高血压防治进.pptVIP

  • 3
  • 0
  • 约2.79万字
  • 约 63页
  • 2019-06-29 发布于湖北
  • 举报
* The principal finding of VALUE was that, for the primary composite endpoint of cardiac mortality and morbidity, there were no significant differences in these high-risk patients treated with valsartan- or amlodipine-based regimens.1 This was observed despite significant differences in achieved blood pressures. In a recent meta-regression analysis based on 30 hypertension trials with 149,407 patients, differences in achieved SBP were found to largely account for cardiovascular outcomes.2 1. Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk

文档评论(0)

1亿VIP精品文档

相关文档